CNX
52
-3
RSG
62
2
HP
67
-8
CAT
62
3
JBHT
45
-13
XRX
55
6
LOW
52
3
WHR
79
2
IP
59
3
GOOG
67
2
EQIX
62
3
AME
53
2
CCL
61
3
FLR
55
5
CCI
25
-13
MSI
49
2
SCHW
61
5
DTE
67
2
ABT
60
-2
MAR
48
-3
CNX
52
-3
RSG
62
2
HP
67
-8
CAT
62
3
JBHT
45
-13
XRX
55
6
LOW
52
3
WHR
79
2
IP
59
3
GOOG
67
2
EQIX
62
3
AME
53
2
CCL
61
3
FLR
55
5
CCI
25
-13
MSI
49
2
SCHW
61
5
DTE
67
2
ABT
60
-2
MAR
48
-3
Financhill
Back

LENZ Therapeutics Stock Predictions

Access "King of the Quants" Stock Rating System FREE!

[Claim Your 3 Free Grades Now]
Sell
6

LENZ
LENZ Therapeutics

Last Price:
$22.56
Seasonality Move:
-8.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Access to "King of the Quants" Stock Rating System

[Claim Your 3 Free Grades Now]

LENZ Therapeutics Stock Forecast

  • Over the next 52 weeks, LENZ Therapeutics has on average historically fallen by 8.1% based on the past 3 years of stock performance.
  • LENZ Therapeutics has fallen lower in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is LENZ Therapeutics Stock Undervalued?
    The current LENZ Therapeutics [LENZ] share price is $22.50. The Score for LENZ is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • LENZ is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will LENZ Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, LENZ Therapeutics has on average historically fallen by 8.1% based on the past 3 years of stock performance.

LENZ Therapeutics Stock Rating

Sell
6
LENZ Therapeutics (LENZ) is a Sell

Is LENZ Therapeutics overpriced?

  • LENZ Therapeutics has fallen lower in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

LENZ Therapeutics Stock Price History

Is LENZ stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LENZ is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lenz-tx.com

52-Week Data

52-Week High:
38.93
52-Week Low:
14.42

Prediction Charts

Market Cap:
618.8M
Price in USD:
22.50
Volume:
143.4K
Beta:
0.58

Technical Analysis

SMA50:
31.60
SMA100:
27.82
SMA200:
23.49
52-Wk Change:
16.46%

Stock Predictions

  • Is LENZ Therapeutics stock public?
    Yes, LENZ Therapeutics is a publicly traded company.
  • What is the LENZ Therapeutics stock quote today?
    The LENZ Therapeutics stock price is 22.50 USD today.
  • How to buy LENZ Therapeutics stock online?
    You can buy LENZ Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-27 31.47 31.32 32.64 30.95
Dec-30 30.58 30.07 30.96 29.45
Dec-31 30.07 28.87 30.61 28.63
Jan-2 29.03 28.29 29.53 28.07
Jan-3 28.57 28.46 29.11 27.60
Jan-6 28.45 27.26 28.45 27.15
Jan-7 27.06 27.18 27.86 26.64
Jan-8 27.18 26.34 27.18 26.10
Jan-10 25.52 23.21 25.82 23.10
Jan-13 23.53 23.20 23.69 22.09
Jan-14 23.47 22.36 23.58 21.80
Jan-15 23.24 22.91 23.84 22.42
Jan-16 22.69 22.40 23.04 21.34
Jan-17 22.64 22.50 23.47 22.34

LENZ Therapeutics Earnings

LENZ Therapeutics Earnings Report: Per Share LENZ Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

LENZ Therapeutics Forecast Revenue Growth

LENZ Therapeutics Stock Analysis: Historical quarterly revenues per share for LENZ Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.50 per share.

* LENZ Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.